Bradykinin Nexus
Our mission is to advance medical knowledge by providing healthcare professionals and providers with accessible, scientifically rigorous information.
MISSION STATEMENT
What We Do
We are committed to fostering collaboration, supporting clinical excellence, and facilitating informed decisions through trusted scientific engagement and educational resources.
US Expanded Access Program (EAP)
Pharvaris has established a US Expanded Access Program for deucrictibant, an investigational medication currently under evaluation for the treatment of hereditary angioedema (HAE).
If you have questions or would like additional details, please contact our Medical department at
expandedaccess.pharvaris@
paragraph
paragraph .biggerbody